Amyris Announces Over $25 Million in Grants
17 janv. 2018 08h30 HE | Amyris, Inc.
Starts 2018 with Strong Continued Momentum EMERYVILLE, Calif., Jan. 17, 2018 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced two grants that have...
Amyris_Purple.png
DSM and Amyris Close Transactions for Brazilian Production Facility
29 déc. 2017 08h30 HE | Amyris, Inc.
HEERLEN, the Netherlands and EMERYVILLE, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Royal DSM (AEX:DSM.AS), a global science-based company active in health, nutrition and materials and Amyris, Inc....
Amyris_Purple.png
Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for Tuesday, November 28, 2017
21 nov. 2017 08h30 HE | Amyris, Inc.
EMERYVILLE, Calif., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) today announced that it will hold a special teleconference to provide additional details on its recently announced...
Amyris_Purple.png
DSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from Amyris
17 nov. 2017 08h30 HE | Amyris, Inc.; Royal DSM
HEERLEN, The Netherlands and EMERYVILLE, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Royal DSM (AEX:DSM.AS), a global science-based company active in health, nutrition and materials and Amyris, Inc....
Amyris_Purple.png
Amyris Reports Another Strong Quarter of Product Sales Growth and Expects Strong Finish for 2017
14 nov. 2017 16h07 HE | Amyris, Inc.
Q3 2017 GAAP revenues of $24.2 million (excludes $8.3 million for an upfront license agreement with Royal DSM executed in Q3 and fully paid early in Q4 2017) and Non-GAAP Q3 revenues of $32.5 million...
Amyris_Purple.png
Amyris Reschedules Third Quarter 2017 Financial Results Teleconference for Tuesday, November 14, 2017
07 nov. 2017 18h02 HE | Amyris, Inc.
EMERYVILLE, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) today announced that it is rescheduling the release of its financial results for the third quarter ended September...
Amyris_Purple.png
H&R Makes Equity Investment in Novvi and its High-Performance Renewable Base Oil Technology
26 oct. 2017 08h30 HE | Amyris, Inc.
HAMBURG, Germany and EMERYVILLE, Calif., Oct. 26, 2017 (GLOBE NEWSWIRE) -- H&R USA (H&R), a company of The Hansen & Rosenthal Group, of Hamburg (Germany), and Novvi LLC today announced...
Amyris_Purple.png
Amyris to Announce Third Quarter 2017 Financial Results on Wednesday, November 8, 2017
25 oct. 2017 08h30 HE | Amyris, Inc.
EMERYVILLE, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS) will report financial results for the third quarter ended September 30, 2017 after market close on Wednesday,...
Amyris_Purple.png
Amyris Appoints Chief Operating Officer to Support Continued Strong Growth
09 oct. 2017 08h30 HE | Amyris
EMERYVILLE, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that Eduardo Alvarez, an experienced executive who has led...
Amyris_Purple.png
Amyris Enters into Product Development and Production Agreement with Royal DSM for Human Nutrition Ingredient
05 oct. 2017 08h30 HE | Amyris
EMERYVILLE, Calif., Oct. 05, 2017 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, today announced that it has entered into a product development and production...